Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 10, 2002, Pages 1351-1355

  Suzuki, Toyofumi ^a   Moriki, Yoshiaki ^a   Goto, Hiroko ^a   Tomono, Kazuo ^a   Hanano, Manabu ^a   Watanabe, Jun ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Brain uptake index; Carrier mediated transport; Pentazocine; Rat

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; DIPHENHYDRAMINE; DRUG CARRIER; EPTAZOCINE; IMIPRAMINE; LIDOCAINE; MEPYRAMINE; NALOXONE; NARCOTIC ANTAGONIST; OPIATE ANTAGONIST; PENTAZOCINE; PROPRANOLOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CAROTID ARTERY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TRANSPORT; DRUG UPTAKE; IN VIVO STUDY; INJECTION; KINETICS; MICHAELIS CONSTANT; NONHUMAN; RAT; ANIMAL; COMMON CAROTID ARTERY; DOSE RESPONSE; DRUG EFFECT; FEMALE; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CAROTID ARTERY, COMMON; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; PENTAZOCINE; RATS; RATS, WISTAR;

EID: 0036782597     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1351     Document Type: Article

References (24)

1. Jasinski D. R., Martin W. R., Hoeldtke R. D., Clin. Pharmacol. Ther., 11, 385-403 (1970).
2. Yokogawa K., Nakashima E., Ishizaki J., Maeda H., Nagano T., Ichimura F., Pharm. Res., 7, 691-696 (1990).
3. El-Mazati A. M., Way E. L., J. Pharmacol. Exp. Ther., 177, 332-341 (1971).
4. Berkowitz B. A., Way E. L., J. Pharmacol. Exp. Ther., 177, 500-508 (1971).
5. Medzihradsky F., Ahmad K., Life Sci., 10, 711-720 (1971).
6. Ichimura F., Yokogawa K., Yamana T., Tsuji A., Mizukami Y., Int. J. Pharmaceut., 15, 321-333 (1983).
7. Suzuki T., Oshimi M., Tomono K., Hanano M., Watanabe J., J. Pharm. Sci., 91, in press (2002).
8. Bonate P. L., J. Neurosci. Methods, 56, 1-15 (1995).
9. Foster K. A., Roberts M. S., Curr. Drug Metab., 1, 333-356 (2000).
10. Oldendolf W. H., Brain Res., 24, 372-376 (1970).
11. Pardridge W. M., Landaw E. M., Miller L. P., Braun L. D., Oldendorf W. H., J. Cereb. Blood Flow Metab., 5, 576-583 (1985).
12. Terasaki T., Pardridge W. M., Denson D. D., J. Pharmacol. Exp. Ther., 239, 724-729 (1986).
13. Pardridge W. M., Fierer G., J. Cereb. Blood Flow Metab., 5, 275-281 (1985).
14. Pardridge W. M., Sakiyama R., Fierer G., Am. J. Physiol., 247, R582-R588 (1984).
15. Yamazaki M., Fukuoka H., Nagata O., Kato H., Ito Y., Terasaki T., Tsuji A., Biol. Pharm. Bull., 17, 676-679 (1994).
16. Yamazaki M., Terasaki T., Yoshioka K., Nagata O., Kato H., Ito Y., Tsuji A., Pharm. Res., 11, 975-978 (1994).
17. Yamazaki M., Terasaki T., Yoshioka K., Nagata O., Kato H., Ito Y., Tsuji A., Pharm. Res., 11, 1516-1518 (1994).
18. Goldberg M. J., Spector R., Chiang C.-K., J. Pharmacol. Exp. Ther., 240, 717-722 (1987).
19. Spector R., J. Pharmacol. Exp. Ther., 244, 516-519 (1988).
20. Sawada N., Takanaga H., Matsuo H., Naito M., Tsuruo T., Sawada Y., J. Pharm. Pharmacol., 51, 847-852 (1999).
21. Murakami H., Sawada N., Koyabu N., Ohtani H., Sawada Y., Pharm Res., 17, 1526-1530 (2000).
22. Allen D. D., Smith Q. R., J. Neurochem., 76, 1032-1041 (2001).
23. Callaghan R., Riordan J. R., J. Biol. Chem., 268, 16059-16064 (1993).
24. Hofsli E., Nissen-Meyer J., Cancer Res., 50, 3997-4002 (1990).